Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lisa A Teot, M.D.

Co-Author

This page shows the publications co-authored by Lisa Teot and Mark Gebhardt.
Connection Strength

0.375
  1. Knee pain in a 9-year-old girl. Clin Orthop Relat Res. 2013 Oct; 471(10):3367-71.
    View in: PubMed
    Score: 0.139
  2. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50.
    View in: PubMed
    Score: 0.051
  3. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408.
    View in: PubMed
    Score: 0.043
  4. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2016 10; 63(10):1737-43.
    View in: PubMed
    Score: 0.042
  5. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61.
    View in: PubMed
    Score: 0.041
  6. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. J Clin Oncol. 2015 Jul 10; 33(20):2279-87.
    View in: PubMed
    Score: 0.040
  7. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9(4):422-41.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.